Yona Levites Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease University of Florida Biography Publications Institution JoVE Articles Yona Levites has not added a biography. If you are Yona Levites and would like to personalize this page please email our Author Liaison for assistance. Publications Induction of CNS α-synuclein Pathology by Fibrillar and Non-amyloidogenic Recombinant α-synuclein Acta Neuropathologica Communications. 2013 | Pubmed ID: 24252149 Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain PloS One. 2013 | Pubmed ID: 23825679 Robust Cytoplasmic Accumulation of Phosphorylated TDP-43 in Transgenic Models of Tauopathy Acta Neuropathologica. Jul, 2013 | Pubmed ID: 23666556 Viral Transduction of the Neonatal Brain Delivers Controllable Genetic Mosaicism for Visualising and Manipulating Neuronal Circuits in Vivo The European Journal of Neuroscience. Apr, 2013 | Pubmed ID: 23347239 Aβ Alters the Connectivity of Olfactory Neurons in the Absence of Amyloid Plaques in Vivo Nature Communications. 2012 | Pubmed ID: 22910355 Overlapping Profiles of Aβ Peptides in the Alzheimer's Disease and Pathological Aging Brains Alzheimer's Research & Therapy. 2012 | Pubmed ID: 22621179 Bispecific Tandem Single Chain Antibody Simultaneously Inhibits β-secretase and Promotes α-secretase Processing of AβPP Journal of Alzheimer's Disease : JAD. 2012 | Pubmed ID: 22156046 Inhibiting β-secretase Activity in Alzheimer's Disease Cell Models with Single-chain Antibodies Specifically Targeting APP Journal of Molecular Biology. Jan, 2011 | Pubmed ID: 21073877 Massive Gliosis Induced by Interleukin-6 Suppresses Abeta Deposition in Vivo: Evidence Against Inflammation As a Driving Force for Amyloid Deposition FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Feb, 2010 | Pubmed ID: 19825975 Generating Differentially Targeted Amyloid-beta Specific Intrabodies As a Passive Vaccination Strategy for Alzheimer's Disease Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2009 | Pubmed ID: 19638957 Quantitative and Mechanistic Studies of Abeta Immunotherapy CNS & Neurological Disorders Drug Targets. Mar, 2009 | Pubmed ID: 19275635 BRI2 (ITM2b) Inhibits Abeta Deposition in Vivo The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Jun, 2008 | Pubmed ID: 18524908 Rab5 Mediates an Amyloid Precursor Protein Signaling Pathway That Leads to Apoptosis The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Jul, 2007 | Pubmed ID: 17611268 Intracranial Adeno-associated Virus-mediated Delivery of Anti-pan Amyloid Beta, Amyloid Beta40, and Amyloid Beta42 Single-chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Nov, 2006 | Pubmed ID: 17108166 Insights into the Mechanisms of Action of Anti-Abeta Antibodies in Alzheimer's Disease Mouse Models FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Dec, 2006 | Pubmed ID: 17068112 Interleukin-1 Receptor 1 Knockout Has No Effect on Amyloid Deposition in Tg2576 Mice and Does Not Alter Efficacy Following Abeta Immunotherapy Journal of Neuroinflammation. 2006 | Pubmed ID: 16872492 Anti-Abeta42- and Anti-Abeta40-specific MAbs Attenuate Amyloid Deposition in an Alzheimer Disease Mouse Model The Journal of Clinical Investigation. Jan, 2006 | Pubmed ID: 16341263 Neuroprotective Strategies in Parkinson's Disease : an Update on Progress CNS Drugs. 2003 | Pubmed ID: 12873156 Neuroprotection and Neurorescue Against Abeta Toxicity and PKC-dependent Release of Nonamyloidogenic Soluble Precursor Protein by Green Tea Polyphenol (-)-epigallocatechin-3-gallate FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. May, 2003 | Pubmed ID: 12670874 Early and Late Molecular Events in Neurodegeneration and Neuroprotection in Parkinson's Disease MPTP Model As Assessed by CDNA Microarray; the Role of Iron Neurotoxicity Research. Nov-Dec, 2002 | Pubmed ID: 12709306 Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (-)-epigallocatechin 3-gallate Neuroprotective Action The Journal of Biological Chemistry. Aug, 2002 | Pubmed ID: 12058035 Attenuation of 6-hydroxydopamine (6-OHDA)-induced Nuclear Factor-kappaB (NF-kappaB) Activation and Cell Death by Tea Extracts in Neuronal Cultures Biochemical Pharmacology. Jan, 2002 | Pubmed ID: 11754870 Intracerebroventricular Viral Injektion der Neonatal Maus Gehirn für anhaltenden und verbreiteten Neuronale Transduction Ji-Yoen Kim*1, Stacy D. Grunke*1, Yona Levites2, Todd E. Golde2, Joanna L. Jankowsky1,3 1Department of Neuroscience, Baylor College of Medicine, 2Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, University of Florida, 3Department of Neurology and Department of Neurosurgery, Baylor College of Medicine Neuroscience
Intracerebroventricular Viral Injektion der Neonatal Maus Gehirn für anhaltenden und verbreiteten Neuronale Transduction Ji-Yoen Kim*1, Stacy D. Grunke*1, Yona Levites2, Todd E. Golde2, Joanna L. Jankowsky1,3 1Department of Neuroscience, Baylor College of Medicine, 2Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, University of Florida, 3Department of Neurology and Department of Neurosurgery, Baylor College of Medicine Neuroscience
